Potential miRNAs for miRNA-Based Therapeutics in Breast Cancer
MicroRNAs (miRNAs) are small non-coding RNAs that can post-transcriptionally regulate the genes involved in critical cellular processes. The aberrant expressions of oncogenic or tumor suppressor miRNAs have been associated with cancer progression and malignancies. This resulted in the dysregulation...
Main Authors: | Jun Sheng Wong, Yoke Kqueen Cheah |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Non-Coding RNA |
Subjects: | |
Online Access: | https://www.mdpi.com/2311-553X/6/3/29 |
Similar Items
-
Clinical Translatability of “Identified” Circulating miRNAs for Diagnosing Breast Cancer: Overview and Update
by: Anna Maria Grimaldi, et al.
Published: (2019-06-01) -
MiRNAs and miRNA Polymorphisms Modify Drug Response
by: Mu-Peng Li, et al.
Published: (2016-11-01) -
Control of Immunoregulatory Molecules by miRNAs in T Cell Activation
by: Ana Rodríguez-Galán, et al.
Published: (2018-09-01) -
MicroRNAs signatures, bioinformatics analysis of miRNAs, miRNA mimics and antagonists, and miRNA therapeutics in osteosarcoma
by: Babak Otoukesh, et al.
Published: (2020-06-01) -
Association of Chromosomal Translocation and MiRNA Expression with The Pathogenesis of Multiple Myeloma
by: Najmaldin Saki, et al.
Published: (2014-06-01)